Arlington Trust’s Astrana Health ASTH Stock Holding History

Arlington Trust’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-33	Closed	-$1.26K	–	911
2023 Q4	$1.26K	Buy	+33	New	+$1.1K	﹤0.01%	777

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arlington Trust's ASTH Position: Q1 2024 in Review

Arlington Trust sold out of Astrana Health (ASTH) in Q1 2024, closing a stake of 33 shares — an estimated $1.26K sold.

Arlington Trust first reported a position in ASTH in Q4 2023 and held it in 1 quarter. The position peaked at $1.26K in Q4 2023. 159 funds tracked by Wall St. Rank hold ASTH as of Q1 2024.

Arlington Trust reported no remaining Astrana Health position as of Q1 2024 after selling out during the quarter.
Arlington Trust sold 33 Astrana Health shares in Q1 2024, an estimated $1.26K.
Arlington Trust first reported a position in Astrana Health in Q4 2023 and held it in 1 quarter.
Arlington Trust's Astrana Health position peaked at $1.26K in Q4 2023.
159 funds tracked by Wall St. Rank held Astrana Health as of Q1 2024.

Based on Arlington Trust's 13F filing for Q1 2024, filed 16 Apr 2024.